Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-06-05 5:19 pm Purchase |
2025-05-29 | 13G | PlayAGS, Inc. AGS |
Glazer Capital, LLC | 2,310,360 5.570% |
2,310,360 (New Position) |
Filing History |
| 2025-06-04 5:24 pm Purchase |
2025-05-28 | 13G | Vigil Neuroscience, Inc. VIGL |
Glazer Capital, LLC | 2,513,462 5.390% |
2,513,462 (New Position) |
Filing History |
| 2025-06-04 5:09 pm Purchase |
2025-05-28 | 13G | Inozyme Pharma, Inc. INZY |
Glazer Capital, LLC | 4,251,940 6.590% |
4,251,940 (New Position) |
Filing History |
| 2025-05-30 4:32 pm Purchase |
2025-05-27 | 13G | E2open Parent Holdings, Inc. ETWO |
Glazer Capital, LLC | 22,614,623 7.270% |
22,614,623 (New Position) |
Filing History |
| 2025-05-30 4:29 pm Purchase |
2025-05-23 | 13G | PHX Minerals Inc. PHX |
Glazer Capital, LLC | 3,489,541 9.200% |
3,489,541 (New Position) |
Filing History |
| 2025-05-20 2:20 pm Purchase |
2025-05-13 | 13G | Everi Holdings Inc. EVRI |
Glazer Capital, LLC | 4,917,214 5.660% |
4,917,214 (New Position) |
Filing History |
| 2025-05-15 4:35 pm Sale |
2025-03-31 | 13G | Zuora, Inc. ZUO |
Glazer Capital, LLC | 0 0.000% |
-8,372,609 (Position Closed) |
Filing History |
| 2025-05-15 4:34 pm Sale |
2025-03-31 | 13G | TECHNOLOGY & TELECOMMUNICATION TETEF |
Glazer Capital, LLC | 0 0.000% |
-408,686 (Position Closed) |
Filing History |
| 2025-05-15 4:33 pm Sale |
2025-03-31 | 13G | Revance Therapeutics, Inc. RVNC |
Glazer Capital, LLC | 0 0.000% |
-7,210,121 (Position Closed) |
Filing History |
| 2025-05-15 4:32 pm Purchase |
2025-03-31 | 13G | Maywood Acquisition Corp. MAYA |
Glazer Capital, LLC | 594,564 6.890% |
594,564 (New Position) |
Filing History |
| 2025-05-15 4:30 pm Purchase |
2025-03-31 | 13G | Logility Supply Chain Solutions, Inc. LGTY |
Glazer Capital, LLC | 2,909,214 7.410% |
1,185,673 (+68.79%) |
Filing History |
| 2025-05-15 4:29 pm Purchase |
2025-03-31 | 13G | Hennessy Capital Investment Corp. VII HVII |
Glazer Capital, LLC | 1,027,505 5.220% |
1,027,505 (New Position) |
Filing History |
| 2025-05-15 4:28 pm Sale |
2025-03-31 | 13G | EVERGREEN CORP EGRVF |
Glazer Capital, LLC | 199,986 7.300% |
-497,668 (-71.33%) |
Filing History |
| 2025-05-15 4:25 pm Sale |
2025-03-31 | 13G | Embrace Change Acquisition Corp. EMCG |
Glazer Capital, LLC | 79,885 1.770% |
-150,115 (-65.27%) |
Filing History |
| 2025-05-15 4:22 pm Purchase |
2025-03-31 | 13G | Dynamix Corporation DYNX |
Glazer Capital, LLC | 1,025,006 6.170% |
1,025,006 (New Position) |
Filing History |
| 2025-05-15 4:20 pm Sale |
2025-03-31 | 13G | Daseke, Inc. DSKE |
Glazer Capital, LLC | 0 0.000% |
-2,394,169 (Position Closed) |
Filing History |
| 2025-05-15 4:17 pm Purchase |
2025-03-31 | 13G | Drugs Made In America Acquisition Corp. Ordinary Shares DMAA |
Glazer Capital, LLC | 1,822,952 5.440% |
1,822,952 (New Position) |
Filing History |
| 2025-05-15 4:14 pm Sale |
2025-03-31 | 13G | Innovid Corp. CTV |
Glazer Capital, LLC | 0 0.000% |
-7,841,568 (Position Closed) |
Filing History |
| 2025-05-15 4:13 pm Purchase |
2025-03-31 | 13G | Checkpoint Therapeutics, Inc. CKPT |
Glazer Capital, LLC | 3,165,000 3.810% |
77,948 (+2.52%) |
Filing History |
| 2025-05-15 4:07 pm Sale |
2025-03-31 | 13G | Avid Bioservices, Inc. CDMO |
Glazer Capital, LLC | 0 0.000% |
-3,394,114 (Position Closed) |
Filing History |